Publications (138) Manuel Nicolás Hernández Guerra de Aguilar publications

filter_list

2024

  1. Agreement between the perception of colon cleansing reported by patients and colon cleansing assessed by a validated colon cleansing scale

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 2, pp. 130-139

  2. Comparative Study of Predictive Models for the Detection of Patients at High Risk of Inadequate Colonic Cleansing

    Journal of Personalized Medicine, Vol. 14, Núm. 1

  3. Cost-effectiveness Analysis of Single-Use Duodenoscope Applied to Endoscopic Retrograde Cholangiopancreatography

    Pancreas, Vol. 53, Núm. 4, pp. E357-E367

  4. Design and validation of an artificial intelligence system to detect the quality of colon cleansing before colonoscopy

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 5, pp. 481-490

  5. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 10, pp. 2062-2074.e11

  6. Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615

  7. Postcolonoscopy colorectal cancer: Prevalence, categorization and root-cause analysis based on the World Endoscopic Organization system

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 319-326

  8. Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis

    Hepatology, Vol. 79, Núm. 3, pp. 624-635

  9. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding

    Journal of Hepatology, Vol. 80, Núm. 1, pp. 73-81

  10. Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy

    Hepatology (Baltimore, Md.), Vol. 80, Núm. 4, pp. 791-806

  11. Programa de certificación de Centros de Adicciones para la eliminación del virus de la hepatitis C en España. Proyecto HepCelentes

    Adicciones: Revista de socidrogalcohol, Vol. 36, Núm. 2, pp. 129-144

  12. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211